|
1
|
Heinlen LD, McClain MT, Merrill J, et al:
Clinical criteria for systemic lupus erythematosus precede
diagnosis, and associated autoantibodies are present before
clinical symptoms. Arthritis Rheum. 56:2344–2351. 2007. View Article : Google Scholar
|
|
2
|
Beebe AM, Cua DJ and de Waal Malefyt R:
The role of interleukin-10 in autoimmune disease: systemic lupus
erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth
Factor Rev. 13:403–412. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Houssiau FA, Lefebvre C, Vanden Berghe M,
et al: Serum interleukin 10 titers in systemic lupus erythematosus
reflect disease activity. Lupus. 4:393–395. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mongan AE, Ramdahin S and Warrington RJ:
Interleukin-10 response abnormalities in systemic lupus
erythematosus. Scand J Immunol. 46:406–412. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mok CC and Lau CS: Pathogenesis of
systemic lupus erythematosus. J Clin Pathol. 56:481–490. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sprengers D, Stoop JN, Binda RS, et al:
Induction of regulatory T-cells and interleukin-10-producing cells
in non-responders to pegylated interferon-alpha therapy for chronic
hepatitis B. Antivir Ther. 12:1087–1096. 2007.PubMed/NCBI
|
|
7
|
Ray A, Basu S, Williams CB, et al: A novel
IL-10-independent regulatory role for B cells in suppressing
autoimmunity by maintenance of regulatory T cells via GITR ligand.
J Immunol. 188:3188–3198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jankovic D, Kullberg MC, Feng CG, et al:
Conventional T-bet(+)Foxp3(−) Th1 cells are the major source of
host-protective regulatory IL-10 during intracellular protozoan
infection. J Exp Med. 204:273–283. 2007.
|
|
9
|
Liu Y, Wei SH, Ho AS, et al: Expression
cloning and characterization of a human IL-10 receptor. J Immunol.
152:1821–1829. 1994.PubMed/NCBI
|
|
10
|
Ho AS, Wei SH, Mui AL, et al: Functional
regions of the mouse interleukin-10 receptor cytoplasmic domain.
Mol Cell Biol. 15:5043–5053. 1995.PubMed/NCBI
|
|
11
|
Riley JK, Takeda K, Akira S, et al:
Interleukin-10 receptor signaling through the JAK-STAT pathway.
Requirement for two distinct receptor-derived signals for
anti-inflammatory action. J Biol Chem. 274:16513–16521. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moore KW, de Waal Malefyt R, Coffman RL,
et al: Interleukin-10 and the interleukin-10 receptor. Annu Rev
Immunol. 19:683–765. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qi ZM, Wang J, Sun ZR, et al: Polymorphism
of the mouse gene for the interleukin 10 receptor alpha chain
(Il10ra) and its association with the autoimmune phenotype.
Immunogenetics. 57:697–702. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P,
Robert ME, McNiff J, Madaio MP and Craft J: IL-10 regulates murine
lupus. J Immunol. 169:2148–2155. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akdis CA and Blaser K: Mechanisms of
interleukin-10-mediated immune suppression. Immunology.
103:131–136. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou M, Ding L, Peng H, et al: Association
of the interleukin-10 gene polymorphism (−1082A/G) with systemic
lupus erythematosus: a meta-analysis. Lupus. 22:128–135. 2013.
|
|
17
|
Donnelly RP, Dickensheets H and Finbloom
DS: The interleukin-10 signal transduction pathway and regulation
of gene expression in mononuclear phagocytes. J Interferon Cytokine
Res. 19:563–573. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peeva E, Venkatesh J, Michael D and
Diamond B: Prolactin as a modulator of B cell function:
implications for SLE. Biomed Pharmacother. 58:310–319. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Valencia-Pacheco G, Layseca-Espinosa E,
Niño-Moreno P, et al: Expression and function of IL-10R in
mononuclear cells from patients with systemic lupus erythematosus.
Scand J Rheumatol. 35:368–378. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Teichmann LL, Kashgarian M, Weaver CT, et
al: B cell-derived IL-10 does not regulate spontaneous systemic
autoimmunity in MRL.Fas(lpr) mice. J Immunol. 188:678–685. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blair PA, Chavez-Rueda KA, Evans JG, et
al: Selective targeting of B cells with agonistic anti-CD40 is an
efficacious strategy for the generation of induced regulatory
T2-like B cells and for the suppression of lupus in MRL/lpr mice. J
Immunol. 182:3492–3502. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Biswas PS, Pedicord V, Ploss A, et al:
Pathogen-specific CD8 T Cell responses are directly inhibited by
IL-10. J Immunol. 179:4520–4528. 2007. View Article : Google Scholar : PubMed/NCBI
|
